CCC
RNTX

Cable Car Capital’s Rein Therapeutics RNTX Stock Holding History

Cable Car Capital’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.4M Buy
5,195,000
+4,775,000
+1,137% +$5.78M 0.12% 59
2026
Q1 		$546K Hold
420,000
– – 0.19% 74
2025
Q4 		$487K Hold
420,000
– – 0.02% 70
2025
Q3 		$481K Hold
420,000
– – 0.21% 49
2025
Q2 		$588K Hold
420,000
– – 0.19% 34
2025
Q1 		$743K Hold
420,000
– – 0.84% 30
2024
Q4 		$966K Hold
420,000
– – 0.04% 63
2024
Q3 		$1.49M Hold
420,000
– – 1.59% 20
2024
Q2 		$1.16M Buy
+420,000
New +$1.73M 1.23% 23

Other funds holding RNTX

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Cable Car Capital's RNTX Position: Q2 2026 in Review

Cable Car Capital increased its Rein Therapeutics (RNTX) stake by 1,137% in Q2 2026, buying an estimated $5.78M and bringing the position to 5,195,000 shares worth $5.4M. The position accounts for 0.12% of the portfolio, ranked #59.

Cable Car Capital first reported a position in RNTX in Q2 2024 and has held it in 9 quarters since. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Cable Car Capital held 5,195,000 shares of Rein Therapeutics worth $5.4M as of Q2 2026.
  • Cable Car Capital bought 4,775,000 Rein Therapeutics shares in Q2 2026, an estimated $5.78M.
  • Rein Therapeutics made up 0.12% of Cable Car Capital's portfolio in Q2 2026, its #59 holding.
  • Cable Car Capital first reported a position in Rein Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Cable Car Capital's 13F filing for Q2 2026, filed 14 Aug 2026.